OTHER
Report from the 15th Congress of the Polish Society of Nephrology
More details
Hide details
1
Military Institute of Medicine – National Research Institute, Department of Internal Medicine, Nephrology and Dialysis, Poland
2
Wojskowy Instytut Medyczny – Państwowy Instytut Badawczy, Klinika Chorób Wewnętrznych, Nefrologii i Dializoterapii, Polska
Submission date: 2025-08-24
Final revision date: 2025-09-05
Acceptance date: 2025-09-08
Publication date: 2025-12-30
Corresponding author
Katarzyna Romejko
Wojskowy Instytut Medyczny – Państwowy Instytut Badawczy, Klinika Chorób Wewnętrznych, Nefrologii i Dializoterapii, ul. Szaserów 128, 04-141, Warszawa, Polska
LW 2025;103(4):347-357
KEYWORDS
TOPICS
ABSTRACT
This year’s Congress of the Polish Society of Nephrology was held in Katowice on June 12–14. During the Congress, the current recommendations of the Polish Society of Nephrology on modern diagnostic and therapeutic modalities for kidney diseases were presented. New possibilities of pharmacological nephroprotection in chronic kidney disease were discussed. Several lectures focused on the innovative treatment of hyperkalaemia. Also, the guidelines on the use of intravenous contrast agents and therapeutic strategies for reducing cardiovascular risk in patients with chronic kidney disease were presented. An important part of the Congress consisted of lectures on hereditary kidney diseases and modern treatment approaches in IgA nephropathy. Finally, the organized workshops provided an opportunity to review interesting clinical cases and update knowledge on the benefits of a low-protein diet in patients with chronic kidney disease.